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'calculate_fluxes.m':
File contains the Matlab implementation of the cancer cell metabolic flux state calculation performed in this work. Requires previous installation of the COBRA Toolbox 1 and a linear programming solver such as Gurobi (http://www.gurobi.com/). The most recent version of Gurobi 5 is recommended, which is free for academic use. Code is commented for help. Other required files are contained in code.zip in the Supplenentary Materials.
Supplementary Results

Analysis of alternate objective functions for estimating the metabolic flux states of the NCI60 cell lines
A typical cellular objective assumed for flux balance analysis is the maximization of cellular growth rate. However, since the growth rates were already measured for the NCI60 cell lines, we needed to determine a secondary objective that would provide the best estimate of the cellular metabolic flux state. We tested several plausible objectives: 1) maximizing cytosolic ATP (Supplementary Data). We evaluated these objectives based on the agreement of the predicted fluxes and 13C data for the MCF7 and A549 cell lines 27, 28 . We found that maximizing mitochondrial NADPH production gave the best agreement, while the other candidate objectives failed to reproduce key features of the measured flux states, including correct malate-aspartate shuttle flux and oxygen consumption rates (Supplementary Data).
Alternative hypotheses for principles underlying the Warburg effect
Supplementary Figure 1 shows results referenced in the main text regarding various hypotheses for principles underlying the Warburg effect. We examined a number of hypotheses, including the need for production of biomass precursors (Supplementary Figure 1a) , and various aspects of protein crowding and protein synthesis limitation (Supplementary Figure 1b,c) .
Supplementary Figure 1:
Analysis of alternative hypotheses for principles underlying the Warburg effect. a) Fraction of glucose uptake going to biomass precursor and non-precursor production. The majority of glucose goes to energy production, ending up as CO2. b) Analysis of the average proteome among the NCI60, broken down by functional classification. It is seen that the fraction of metabolic protein involved in oxidative phosphorylation (the TCA cycle and electron transport chain) is small, suggesting that only a marginal amount of protein cost and/or space is saved by shifting from an oxidative to anaerobic energy production phenotype. c) Evaluation of protein crowding metrics vs Warburg effect metrics. No correlation is observed between the protein density and degree of the Warburg effect, quantified by the glucose/lactate ratio. However, dense lines take up greater amounts of glucose, which is the opposite trend that would be expected if the Warburg effect was a response to minimize the proteome due to macromolecular crowding constraints.
Construction and evaluation of genome-scale cell line-specific models
Using the GIMME algorithm 2 and gene 3 and protein 4 expression data for the NCI60 cell line panel, we initially constructed cell line-specific models for the NCI60 cell line panel from the global human reconstruction Recon 2 5 . Briefly, the GIMME algorithm attempts to find a flux state that satisfied measured growth and metabolite uptake/secretion constraints, while using as few reactions called "Absent" in the gene expression data as possible. If a reaction is active in the flux solution but is not expressed, we say that this reaction is "required in the model" but this flux is inconsistent with the expression data. More details are described in the manuscript on the GIMME algorithm 2 .
Growth 6 and metabolite uptake data 7 as well as cell sizes 8 were used to constrain this algorithm. We found that presence in the proteomics data was a good predictor of presence in gene expression data, with a specificity of 0.96, indicating concordance between the data types used in model construction ( Figure S2e ). However, proteomics data only showed a specificity of 0.06 for presence calls in gene expression data. This low specificity is likely a result of both genes that are transcribed but are not translated as well as limitations in experimental proteomics methods.
Metabolic similarities and differences can be determined from these models, as can the value of integrating multiple data types to achieve a more complete and consistent picture of the metabolic state of the cell lines. Transcriptomic data showed that expression certain pathways, notably central metabolism and vitamin metabolism, were highly conserved across the NCI60 cell lines, with greater than 90% of reactions having measured gene expression in the majority of cell lines ( Figure S2b ). This result suggests that the core metabolic network is largely shared among the NCI60 lines, a finding that is somewhat at odds with prior NCI60 model construction efforts that did not include physiological data 9 , which we define as growth rate, cell size, and metabolite uptake and secretion data. It should be noted that physiological data has been shown to be more accurate in quantitatively determining metabolic flux maps than expression profiling data that should be considered semi-quantitative After running the GIMME algorithm, reaction content becomes more diversified between the cell lines ( Figure S2c ). This indicates that although the majority of reactions may be consistently expressed between cell lines, the expression penalty for certain absent reactions may cause entire pathways to be shut off in particular cell lines, as long as these pathways are not forced to be active by growth or measured uptake/secretion requirements. This appears to be a concerning feature of the behavior of the GIMME algorithm. For 88 reactions ( Figure S2d ), metabolite exchange profiles and growth rate data (call functional or physiological data) indicated reactions were active in certain cell lines even though gene expression data was low, highlighting the benefit of incorporating independent data sets in the model construction process.
Notable cases of active but low expressed reactions included Complex II and III from the ETC, several reactions around the urea cycle including ornithine transaminase and argininosuccinate synthase, and the serine synthesis reaction phosphoglycerate dehydrogenase.
After running the GIMME algorithm, we attempted to evaluate and curate the resulting cell-specific models. Specifically, we looked at cases of inconsistencies between the constraints due to growth and metabolite uptake and secretion, and the gene expression data. We term reactions that are expressed ("Present") but cannot carry flux due to constraints "Downregulated", while reactions that are not expressed ("Absent") but are forced to carry flux by constraints "Up-regulated" (Supplementary Data). We attempted to manually curate these cases to determine whether a 'fix' could be made, such as a modification to the constraints, or addition of a possible previously unknown reaction, or identification of a problematic gene expression probe, to resolve the inconsistency. However, this effort ended up being largely unsuccessful.
For illustrative purposes, we include these lists in the Supplementary Data.
From this model curation effort, we decided that the due to the fact that many of the most interesting reaction "Absences" in the expression data were required to be "Present" by growth or metabolite exchange data, little clear value was obtained through the use of these models, as reaction absence called may not be fully trustable. For this reason, we decided to construct a high confidence core metabolic model that was both highly expressed and overlapped with available 13C data that could be used for validation of flux solutions. We also note that our efforts to use cell line-specific models to reproduce the same 13C data were largely unsuccessful.
Supplementary Figure 2:
Construction and evaluation of cell line-specific genome-scale metabolic models of the NCI60 cell lines. a) Workflow for the construction of cell line-specific genome-scale metabolic models. Gene expression, protein expression, and copy number variation data were integrated with the latest human reconstruction Recon 2 using the GIMME algorithm 2 . b) Analysis of reaction content among cell line-specific models. Vitamin and central energy metabolism were highly expressed across all lines, indicative of the fact that these pathways are necessary for growth. However, amino acid metabolism was more variably expressed, possibly due to several alternative biosynthetic and catabolic routes being connected to many amino acids. c) Log plot of reaction presence across the NCI60 cell lines following cellspecific model construction with the GIMME algorithm, indicating variable reaction content between cell lines. d) Analysis of inconsistent reactions among the NCI60 cell lines, where a reaction was not expressed in the gene expression data but was required to be present in the GIMME constraint-based modeling algorithm in order to satisfy growth or metabolite exchange constraints. e) Statistical comparison of the agreement of gene and protein expression data. The calculation of the terms is described in the 7 and growth rate data 6 , both of which were measured in replicate, 23 lines were predicted to not be able to sustain the measured protein content, with several lines substantially deficient. We define the sustainable protein content as the mass of protein that a cell could produce given measured metabolite uptakes and growth rate.
It is a value calculated using flux balance analysis and identifies the largest mass/cell value that allows a feasible flux balance analysis solution constrained by measured metabolite uptakes and growth rate for a particular cell line First we verified that the protein levels were physically consistent with measured cell volumes assuming a protein density of 1.35 g/ml 11 . There was an average protein volume fraction of 0.15, and no volume fraction of protein was higher than 0.4, suggesting that no physical volume constraints were likely to be violated by either the measured or sustainable protein contents. We then examined potential causes of this discrepancy between sustainable and measured protein content. Three possible explanations we identified were that the cells were catabolizing the excess of amino acids for energy, the cells were using the excess amino acids for protein synthesis of secreted protein that would not have been measured, or the cells were using the excess amino acids for protein synthesis of internal proteins and thus the measured protein content were erroneous. Notably, the observation that many lines did not take up enough amino acids to sustain their measured protein is already suggestive of erroneous protein data. To examine the alternatives, we looked at correlations between expression of genes involved in catabolism of essential amino acids as well as genes encoding secreted proteins with the amount of excess amino acids taken up. We observed no widespread correlation of expression of amino acid catabolic genes with excess amino acids taken up, which did not support the idea that an excess of amino acids are taken up.
Instead, we proceeded with the hypothesis that some of the measured protein data was erroneous and sought to correct the data using information from the amount of protein that the cells could sustain production of during growth, and using the measured cellular volumes as was observed between expression of these genes and the observed excess sustainable protein, supporting the notion that this excess sustainable protein is actually being synthesized into internal protein and should be added to the cellular protein content.
To calculate the sustainable protein for use as the cell protein, we performed an FBA optimization to maximize the cell mass subject to measured metabolic uptake and secretion, growth rate, and biomass composition. Cell line-specific biomasses were not taken into account, but previous studies measuring biomass composition found very similar compositions across cell lines and mammalian organisms [12] [13] [14] , suggesting this is not a large source of error. The procedure used is described in the Methods of the main text. The final agreement between corrected protein and measured cellular volumes was noticeably better than for uncorrected protein (Pearson R 2 = 0.60 vs R 2 = 0.23) (Supplementary Fig. 3e ). Amino acids are grouped by common biosynthetic pathway. Group 1 consists of amino acids most closely tied to glutamine uptake. Group 2 consists of amino acids most closely tied to serine uptake. It is seen that by summing amino acids by groups, the net uptake of each group (the Non-essential Groups columns) are highly correlated with essential amino acid uptakes, even more so than serine and glutamine individually.
NADPH production and consumption in the NCI60 cell lines
One additional analysis we performed was to examine the role of the redox cofactors produced by the pathways associated with the high uptake metabolites glucose and serine. We found that growth-associated NADPH demands are dominated by fatty acid and steroid metabolism ( Supplementary Fig. 5a ), and are met by significant contributions to the cytosolic NADPH pool by the pentose phosphate pathway (66%) and folate metabolism (34%), which is in the range of previous estimates 15 ( Supplementary Fig. 5b ). Notably, a large majority of this NADPH production (mean 86%) originates from glucose. Thus, cytosolic NADPH production pathways meet the growth requirement of NADPH for the cell and are powered by glucose uptake.
Supplementary Figure 5: Cytosolic NADPH balance. a) Cytosolic NADPH utilization,
showing dominance of fatty acid and steroid synthesis. b) Cytosolic production of NADPH. The pentose phosphate pathway and folate pathway are both significant contributors, with the pentose phosphate pathway predicted to produce an average of 66% of cytosolic NADPH. However, an even higher fraction of cytosolic NADPH (86%) is glucose-derived rather than serine derived, due to additional NADPH from the glucose-driven de novo serine synthesis pathway.
Analysis of correlation between transporter isozyme expression differences and metabolite uptake flux differences
One auxiliary analysis we performed that was of interest was to examine whether cell line-specific transport isozymes had a noticeable correlation with measured metabolite exchanges. We performed a targeted analysis of transporter kinetics for glucose and lactate, selected due to their high transport flux and degree of annotation of transporters. For each of these metabolites, a large number of transporter isoforms exist (over 15 for glucose, 4 for lactate). We were interested in determining whether the choice of transporter isoforms is associated with a particular metabolic phenotype. We found that, for glucose, expression of the most kinetically efficient glucose transporter, GLUT3, is significantly correlated with glucose uptake (0.0303 Wilcoxon rank sum), suggesting alternate transporter expression as a potential factor underlying differences in growth scaling. However, no association was found for lactate transporter expression.
Supplementary Methods
Normalization and curation of expression data
The construction of cell-specific models was performed using gene expression data.
Triplicate gene expression microarray data for the NCI60 was normalized using GCRMA. Gene presence absence calls used in cell line-specific model construction were generated as follows.
We found that applying a general cutoff for presence worked poorly, based on the ability of cells to satisfy a growth state given the available metabolite uptakes. We attribute this failure to probespecific bias, which we also observed, when multiple probes were present for the same gene.
Instead, we curated each probe and used the presence of triplicate data and fact that expression data was generated in a single study for the NCI60 lines in order to manually assess probe- The A549 cell line data was corrected to account for a substantial difference in measured lactate secretion between the 13 C study and the exometabolomic study 7 . The difference between the two values was used to correct the LDH reaction as well as the reactions affected by the difference in leftover pyruvate from glycolysis, which consists of PDH and PC as well as downstream TCA reactions. As PDH and PC are alternate routes to enter the TCA cycle, they were corrected in the same 90:10 split that was used as a constraint in the flux balance calculations performed in this work.
The MCF7 cell line data was corrected to account for a difference in malate-aspartate shuttle usage between the approximate model used in the 13 C study, which did not have NADH as a metabolite and combined malate, oxaloacetate, and aspartate into a single metabolite MOA (Table 2 in the cited paper), and our fully described reconstruction. The version of cytosolic malic enzyme in their manuscript converts the cytosolic aggregate metabolic MOA to pyruvate.
However, their aggregate malate-aspartate shuttle only accounts for the net loss of this malate pool toward pyruvate, it does not account for the need to shuttle NADH produced by glycolysis into the mitochondria for oxidation. The amount of NADH produced by glycolysis agrees between the 13 C data and our flux calculations and lactate production is insufficient to regenerate NAD at steady-state. Our model is constrained by this NADH production in a way that the approximate model used in the 13 C study is not. The consequence is that our model calculates that the active form of malic enzyme is the mitochondrial form, which is the canonical active form 18 , rather than the cytosolic form as reported in the 13 C study. It is unknown whether placing a correct NADH balance constraint on the model used in the 13 C study would cause their flux solution to prefer the mitochondrial malic enzyme form. Still, operating on the assumption that the NADH balance issue is sufficient reason to doubt the accuracy of the fluxes involving metabolites affected by the malate-asparate shuttle, we corrected the 13 C data as follows. We calculated the difference between the mitochondrial and cytosolic malic enzyme fluxes and used this value to adjust the fluxes affected by the active malic enzyme being mitochondrial. These reactions were isocitrate dehydrogenase, the malate-aspartate shuttle, and PDH and PC. PDH and PC were corrected by this value in the same 90:10 split that was used as a constraint in the flux balance calculation performed in this work.
Supplementary Discussion
The role of metabolic models in providing a structure for data analysis
The quantitative analysis of the required use of the metabolic network to provide the cellular resources (biosynthesis and energy) needed to produce the observed physiological demands reveals a relatively simple basis for observed characteristics of cancer cell metabolism. The regularization of all the data types is based on systems level balancing of mass and energy requirements for observed cellular functions provides a useful framework for the analysis and understanding of the hallmarks of observed metabolic functions in well characterized cancer cell lines. This study shows that disparate data sets on the NCI60 collection of cancer cell lines can be integrated and reconciled using genome-scale models as a context. This approach discovered the overall structure of metabolism in cancer cells appears to be very simple and stoichiometrically determined. It is characterized by two groups of amino acids, the serine and essential amino acid groups, being taken up at net levels primarily set by the protein synthesis demand. Meanwhile, each dominant uptake metabolite is taken up in excess in a manner that fuels production of NADPH and/or ATP above biosynthetic requirements, coupled to an overflow of metabolites at the end of corresponding production pathways but prior to a mitochondrial catabolic pathway.
Gene expression data curation and consistency with measured growth and metabolite exchanges
There appear to be three possible explanations for the observation that many reactions would be called 'off' by expression considerations alone, but are forced to be on to allow a flux state consistent with measured metabolite exchange profiles and growth rates. The first option is that the lowly expressed reaction is not active, and that instead an alternate pathway exists that is providing the metabolic function. Second, it is possible that the reaction is active but the protein catalyzing the reaction is different from the annotated protein, suggesting unknown isozymes exist. Given the large number of cases observed and their location in highly studied pathways, it appears unlikely that such a large number of unknown alternate pathways and/or isozymes exist.
The third possibility is that the reaction is active and the annotated protein is present but in low amounts that are sufficient for catalysis. We believe this last case to be the true case, which raises a potential concern with model construction methods based solely on expression data but lack metabolite uptake/secretion profiles and growth rates.
